Ozette

Seattle, United States Founded: 2021 • Age: 5 yrs
Computational drug discovery platform is developed for immune monitoring.

About Ozette

Ozette is a company based in Seattle (United States) founded in 2021 by Raphael Gottardo, Greg Finak, and Evan Greene. It operates as a AI-as-a-Service, and Professional Services. Ozette has raised $32 million across 2 funding rounds from investors including ARE, Duke University and Allen Institute for Artificial Intelligence. The company has 12 employees as of December 31, 2021. Ozette offers products and services including Ozette Resolve and Computational Analysis Technology. Ozette operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.

  • Headquarter Seattle, United States
  • Employees 12 as on 31 Dec, 2021
  • Founders Raphael Gottardo, Greg Finak, Evan Greene
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ozette Technologies
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $32 M (USD)

    in 2 rounds

  • Latest Funding Round
    $26 M (USD), Series A

    Jul 28, 2022

  • Investors
    ARE

    & 7 more

  • Employee Count
    12

    as on Dec 31, 2021

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Ozette

Ozette offers a comprehensive portfolio of products and services, including Ozette Resolve and Computational Analysis Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Cloud solution for adaptive unmixing of cytometry data.

AI technology for immune system data insights discovery.

People of Ozette
Headcount 10-50
Employee Profiles 23
Board Members and Advisors 6
Employee Profiles
People
Michael Comeau
Associate Director, Strategic Scientific Alliances
People
Wenxin Jiang
Software Engineer
People
Ali Ansary
CEO & Co-Founder
People
Greg Finak
CTO & Co-Founder

Unlock access to complete

Board Members and Advisors
people
Raphael Gottardo
Scientific Advisor & Co-Founder

Unlock access to complete

Funding Insights of Ozette

Ozette has successfully raised a total of $32M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $26.0M
  • First Round

    (16 Feb 2021)

  • Investors Count 8
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2022 Amount Series A - Ozette Valuation Madrona Venture Group
Feb, 2021 Amount Seed - Ozette Valuation Madrona Venture Group
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Ozette

Ozette has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Duke University and Allen Institute for Artificial Intelligence. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital investments in technology startups are facilitated by M12.
Founded Year Domain Location
Venture capital investing in AI, biotech, and technology sectors, focusing on seed and early stages in Seattle and beyond.
Founded Year Domain Location
Venture capital investments are provided by OCV Partners.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Ozette

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Ozette

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Ozette Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Ozette

Ozette operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
An agentic AI platform is developed for biomedical research insights.
domain founded_year HQ Location
AI-powered drug discovery platform for various diseases
domain founded_year HQ Location
AI-based technology is used for recombinant protein production in therapeutics.
domain founded_year HQ Location
Antibody therapies are developed through machine learning and synthetic biology.
domain founded_year HQ Location
AI-based platform for cancer diagnostics and precision medicine is utilized.
domain founded_year HQ Location
AI platform used for extracting antibody data from scientific papers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Ozette

Frequently Asked Questions about Ozette

When was Ozette founded?

Ozette was founded in 2021.

Where is Ozette located?

Ozette is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.

Is Ozette a funded company?

Ozette is a funded company, having raised a total of $32M across 2 funding rounds to date. The company's 1st funding round was a Seed of $6M, raised on Feb 16, 2021.

How many employees does Ozette have?

As of Dec 31, 2021, the latest employee count at Ozette is 12.

What does Ozette do?

Ozette Technologies is engaged in developing AI-driven computational analysis for immune system research. The company offers solutions like Ozette Resolve for spectral cytometry unmixing, aimed at improving data accuracy in discovery and clinical studies. Their technology supports advancements in targeted therapies, particularly in immuno-oncology, by revealing critical insights into immune responses. Partnerships are formed with pharmaceutical and academic organizations to maximize data value across research and clinical development sectors.

Who are the top competitors of Ozette?

Ozette's top competitors include Owkin, Formation Bio and XtalPi.

What products or services does Ozette offer?

Ozette offers Ozette Resolve and Computational Analysis Technology.

Who are Ozette's investors?

Ozette has 8 investors. Key investors include ARE, Duke University, Allen Institute for Artificial Intelligence, M12, and Cercano Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available